Cytosorbents - CTSO Company profit before taxes, interest and amortization
Unstable cash flow resulting from technology implementation costs and R&D currently drives the dynamics of Cytosorbents (CTSO). Absolute EBITDA illustrates the market reaction, where 0.00 expresses the latest level of the metric. Cytosorbents generates revenue from the sale of blood purification cartridges, while the defensive status of the business completely eliminates the impact of macroeconomic downturns on operating results.
Summary analytical data breakdowns for CytoSorbents Corporation (CTSO)
- market price and analyst price targets:
- issuer market value details:
- issuer book value statistics:
- business debt structure and liquidity details:
All Debt to Shareholders' Equity Ratio Cytosorbents|CTSO - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio CytoSorbents Corp|CTSO - Company Aggregate Debts|Debts to Book Value Cytosorbents|CTSO - Company Long-Term Debts|Company Short-Term Indebtedness Cytosorbents|Interim Coverage Ratio cytosorbents.com
- company profitability and valuation multiples indicators:
CTSO - Net Profit|Future Profit Cytosorbents|CTSO - P/E Multiple|Forward P/E Multiple CytoSorbents Corp|CTSO - Price/Earnings to Growth Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Cytosorbents|CTSO - Operating profit before deduction of amortization|Earnings per share for the trailing year Cytosorbents|CTSO - Net earnings per share (EPS TTM)|Earnings per share growth in annualized terms for the last twelve months cytosorbents.com|CTSO - Earnings per share growth in current year|Net earnings per one share growth forecast for next year Cytosorbents
Summary company analytics:Cytosorbents
The monopoly position of Cytosorbents in the cytokine sorption niche and the sale of patented cartridges generate a stable cash flow, which reflects the current EBITDA value of 0.00. This metric measures operating efficiency excluding depreciation and taxes, allowing investors to assess the company's actual ability to service obligations using liquid cash from its core business activities.
Who Cytosorbents competes with
Operating profit EBITDA Dexcom CGM DXCM|PEN: Operating profit before deduction of amortization|novanta.com - Company profit before taxes, interest and amortization|HAE: Operating profit EBITDA|INSP - Operating income before deduction of amortization|PRCT (PROCEPT BioRobotics Inc) - Operating profit EBITDA|Operating profit before deduction of amortization CONMED Inc. (CNMD)|Operating profit before deduction of amortization PLSE (Pulse Biosciences, Inc.)|INMD (inmodemd.com) - Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Picard Medical PMI|SRDX - Operating profit before deduction of amortization|Eversense - Operating profit EBITDA|Profit before interest, taxes and amortization NeuroPace Medical|TCMD: Operating profit EBITDA|Operating profit before amortization SNWV|OM (Outset Medical) - Operating profit EBITDA|Electromed Inc (ELMD) - Operating income before deduction of amortization|Operating profit EBITDA LNSR|Operating profit before deduction of amortization AVITA Medical Inc RCEL|Operating profit EBITDA PROF (Profound Medical)|Operating profit EBITDA Baird Medical Investment Holdings BDMD|EDAP - Profit before payment of interest, taxes and amortization|APYX: Profit before payment of interest, taxes and amortization|ICCM (icecure-medical.com) - Operating profit before deduction of amortization|Pulmonx - Income before deduction of interest, taxes and amortization|TELA (TELA Bio Inc.) - Operating profit EBITDA|Profit before interest, taxes and amortization sensushealthcare.com SRTS|Profit before payment of interest, taxes and amortization Zynex (ZYXI)|electrocore.com (ECOR) - Operating profit before depreciation charges|Vicarious Surgical - Operating profit before deduction of amortization|Operating profit EBITDA Inspira Technologies Oxy B.H.N. Ltd. IINN|SeaStar Medical Holding - Operating profit EBITDA|Operating income before deduction of amortization IRIDEX Corporation IRIX|ibs.inc (INBS) - Profit before payment of interest, taxes and amortization|Profit before deduction of interest, taxes, depreciation and amortization XAIR (Beyond Air)|Profit before payment of interest, taxes and amortization Profusa, Inc.|Operating profit before deduction of amortization STRATA Skin (SSKN)|Operating profit EBITDA GCTK|NAOV - Profit before interest, taxes and amortization|Profit before payment of interest, taxes and amortization Venus Concept VERO|NUWE: Operating profit before amortization|AEMD: Operating profit before deduction of amortization|Asensus Surgical, Inc. - Company profit before taxes, interest and amortization|AVGR: Operating profit EBITDA|Operating profit before deduction of amortization BioSig Technologies Inc.|Operating profit before deduction of amortization CUTR|Profit before interest, taxes and amortization Know Labs Inc KNW|Operating profit before deduction of amortization NARI (Inari)|Company profit before taxes, interest and amortization NVRO|Profit before payment of interest, taxes and amortization ReShape Lifesciences Inc. RSLS|silkroadmed.com (SILK) - Profit before interest, taxes and amortization
